All News

Officials with the FDA have approved talazoparib (Talzenna, Pfizer) for the treatment of HER2-negative locally advanced or metastatic breast cancer with germline BRCA (gBRCA) mutations.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Officials with the Centers for Medicare & Medicaid Services this week proposed requiring drug manufacturers to include prices in direct-to-consumer television advertisements for prescription drugs.

Recent preclinical and population evidence shows cannabis modulates inflammatory and fibrotic processes in the liver, which is promising for treating the symptoms of hepatitis C virus.

Ed Cohen, PharmD, who is Executive Vice President of Pharmacy Advocacy for Pharmacy Times, discusses tips for pharmacists who get questions from patients on the shingles vaccine.

The cannabidiol company and DNA tester will co-market CBD products.

A pair of pivotal Phase 3 placebo-controlled trials that evaluated dupilumab (Dupixent, Sanofi and Regeneron) for adults with inadequately-controlled chronic rhinosinusitis with nasal polyps met all primary and secondary endpoints.

Pharmacy technicians across the country are being honored today in recognition of National Pharmacy Technician Day.

Talazoparib, a poly ADP-ribose polymerase (PARP) inhibitor, is indicated for patients with known deleterious or suspected deleterious gBRCA-mutated breast cancer who are selected for the therapy based on an FDA-approved companion diagnostic.

Talazoparib is indicated for patients with known deleterious or suspected deleterious germline BRCA-mutated HER2-negative locally advanced or metastatic breast cancer.

Low-dose aspirin users may have a lower risk of developing ovarian cancer and hepatocellular carcinoma (HCC), according to 2 new studies published in JAMA Oncology.

Aspirin dose and duration of use may affect the risk of developing ovarian cancer and hepatocellular cancer.

Neoadjuvant therapy with a combination checkpoint blockade produced a high response rate among patients with melanoma.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Study investigates whether direct-acting antiviral drugs for hepatitis C virus increase the risk of developing hepatocellular carcinoma.

Officials with the Pharmaceutical Research and Manufacturing Association (PhRMA) said in a press release that they plan to request member companies’ direct-to-consumer (DTC) television advertisements to direct patients to information about medicine costs, including the list price of the medicine, out-of-pocket costs or other context about the potential cost of the medicine and available financial assistance.

No pharmacy ever developed an outstanding brand without having put together its A-team.

The benefits of adopting blockchain technology have not been overlooked by the health care industry and can have a direct and lasting impact on specialty pharmacy.

Two recently published studies have evaluated prazosin in alcohol use disorder

Obesity and weight gain in early adulthood may be a contributor to increased risk of early-onset colorectal cancer in women under the age of 50.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Can you solve the pharmaceutical mystery? Each week, a new case study is presented.

Fingolimod (Gilenya) found to significantly reduce the annualized relapse rate compared with glatiramer acetate among patients with relapsing-remitting multiple sclerosis.

Business, leadership, and communication are just a few of the other skills needed to be successful in pharmacy administration.

E-cigarettes can be beneficial tool for smoking cessation, but the use of e-cigarettes in minors can be dangerous.

In recognition of the first National Women Pharmacists Day today, October 12, Specialty Pharmacy Times conducted an interview with female pharmacy leaders and a pharmacy student to hear their unique perspectives on the state of the industry, as well as challenges and opportunities in store ownership.

On the first National Women Pharmacists Day, top voices in the field discuss how women are helping to shape the future of pharmacy.